Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray for sedation and analgesia in oral implant surgery
ChiCTR2500097744Phase 4Not yet recruiting
- Sponsor
- The Affiliated Stomatological Hospital of Chongqing Medical University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in Dental anxiety (3 arms), sponsored by The Affiliated Stomatological Hospital of Chongqing Medical University. Primary endpoints: Dental Anxiety Score, Adverse reactions and 4 more. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on ChiCTR2500097744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097744.